This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Wijerathne H , Langston JC , Yang Q , Sun S , Miyamoto C , Kilpatrick LE , Kiani MF
Mechanisms of radiation-induced endothelium damage: emerging models and technologies
Radiother Oncol. 2021 Feb 10;158 :21-32
PMID: 33581220 PMCID: PMC8119342 URL: https://www.ncbi.nlm.nih.gov/pubmed/33581220
AbstractRadiation-induced endothelial/vascular injury is a major complicating factor in radiotherapy and a leading cause of morbidity and mortality in nuclear or radiological catastrophes. Exposure of tissue to ionizing radiation (IR) leads to the release of oxygen radicals and proteases that results in loss of endothelial barrier function and leukocyte dysfunction leading to tissue injury and organ damage. Microvascular endothelial cells are particularly sensitive to ionizing IR and radiation-induced alterations in endothelial cell function are thought to be a critical factor in organ damage through endothelial cell activation, enhanced leukocyte-endothelial cell interactions, increased barrier permeability and initiation of apoptotic pathways. These radiation-induced inflammatory responses are important in early and late radiation pathologies in various organs. A better understanding of mechanisms of radiation-induced endothelium dysfunction is therefore vital, as radiobiological response of endothelium is of major importance for medical management and therapeutic development for radiation injuries. In this review, we summarize the current knowledge of cellular and molecular mechanisms of radiation-induced endothelium damage and their impact on early and late radiation injury. Furthermore, we review established and emerging in vivo and in vitro models that have been developed to study the mechanisms of radiation-induced endothelium damage and to design, develop and rapidly screen therapeutics for treatment of radiation-induced vascular damage. Currently there are no specific therapeutics available to protect against radiation-induced loss of endothelial barrier function, leukocyte dysfunction and resulting organ damage. Developing therapeutics to prevent endothelium dysfunction and normal tissue damage during radiotherapy can serve as the urgently needed medical countermeasures.
Notes1879-0887 Wijerathne, Harshani Langston, Jordan Yang, Qingliang Sun, Shuang Miyamoto, Curtis Kilpatrick, Laurie E Kiani, Mohammad F Journal Article Review Ireland Radiother Oncol. 2021 Feb 10:S0167-8140(21)06056-4. doi: 10.1016/j.radonc.2021.02.007.